(19)
(11) EP 4 770 636 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24861100.6

(22) Date of filing: 30.08.2024
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
C07D 498/18(2006.01)
 A61K 31/435(2006.01)
A61K 31/33(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/436; A61K 31/427; A61K 45/06
 
C-Sets:
  1. A61K 31/436, A61K 2300/00;
  2. A61K 31/427, A61K 2300/00;
(86) International application number:
PCT/US2024/044577
(87) International publication number:
WO 2025/049843 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363580027 P

(71) Applicant: Klee, Trevor
Boston, Massachusetts 02108 (US)

(72) Inventor:
  • Klee, Trevor
    Boston, Massachusetts 02108 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) COMPOSITIONS FOR ACHIEVING EFFECTIVE DOSE LEVELS OF MTOR INHIBITORS